Relapsing Remitting Multiple Sclerosis

Roche’s Ocrevus Shines in Relapsing-Remitting MS, Safety Studies
BioSpace
Thu, 11/3/22 - 07:28 pm
Genentech
Roche
Ocrevus
MS
Relapsing Remitting Multiple Sclerosis
NICE backs Biogen’s Vumerity for multiple sclerosis
Pharmaforum
Wed, 04/13/22 - 10:40 am
Biogen
NICE
UK
Relapsing Remitting Multiple Sclerosis
Vumerity
Novartis’ Gilenya proves superiority over glatiramer acetate in relapsing remitting MS
Pharmaceutical Business Review
Mon, 05/13/19 - 08:14 pm
Novartis
Gilenya
Relapsing Remitting Multiple Sclerosis
Bayer to increase patient access to specialty drugs with ZappRx digital platform
BioCentury
Wed, 01/16/19 - 11:58 am
Bayer
ZappRx
patients
pulmonary hypertension
Relapsing Remitting Multiple Sclerosis
Adempas riociguat
IFNβ-1b Betaferon
Novartis’ Gilenya gets approval in Europe to treat children and adolescents with MS
Pharmaceutical Business Review
Fri, 11/30/18 - 10:21 am
Novartis
Gilenya
Europe
Relapsing Remitting Multiple Sclerosis
Lemtrada Treatment Effects in MS Patients Maintained Over Seven Years
CP Wire
Tue, 04/24/18 - 09:02 am
Sanofi Genzyme
Lemtrada
MS
Relapsing Remitting Multiple Sclerosis
Lemtrada Treatment Effects in MS Patients Maintained Over Seven Years
Tue, 04/24/18 - 02:29 pm
Lemtrada
Sanofi
Relapsing Remitting Multiple Sclerosis
multiple sclerosis
Mylan and Mapi Pharma Partner on Once Monthly Glatiramer Acetate Drug for Relapsing-Remitting MS
CP Wire
Tue, 04/10/18 - 11:24 am
Mylan Labs
Mapi Pharma
GA Depot
MS
Relapsing Remitting Multiple Sclerosis
Teva decides not to proceed to randomization stage of trial for laquinimod
Yahoo/Fly on the Wall
Wed, 02/19/14 - 08:40 am
laquinimod
clinical trials
Teva Pharmaceuticals
Relapsing Remitting Multiple Sclerosis
RRMS
MS
Active Biotech